IRIS
SARMATI, LOREDANA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 53.826
EU - Europa 5.271
AS - Asia 3.666
OC - Oceania 93
SA - Sud America 87
Continente sconosciuto - Info sul continente non disponibili 21
AF - Africa 17
Totale 62.981
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 53.767
SG - Singapore 1.553
IT - Italia 1.164
DE - Germania 790
CN - Cina 734
IE - Irlanda 708
UA - Ucraina 704
KR - Corea 668
HK - Hong Kong 481
RU - Federazione Russa 409
SE - Svezia 369
GB - Regno Unito 285
FR - Francia 245
FI - Finlandia 199
PL - Polonia 131
AU - Australia 84
BE - Belgio 74
CA - Canada 48
ID - Indonesia 48
BR - Brasile 47
CZ - Repubblica Ceca 46
NL - Olanda 46
IN - India 42
ES - Italia 33
JP - Giappone 27
AT - Austria 21
VN - Vietnam 19
KG - Kirghizistan 17
PK - Pakistan 16
EU - Europa 14
CL - Cile 11
CO - Colombia 11
MX - Messico 11
CH - Svizzera 10
NZ - Nuova Zelanda 9
TW - Taiwan 9
IQ - Iraq 8
RO - Romania 8
AR - Argentina 7
TR - Turchia 7
GR - Grecia 6
IL - Israele 6
PH - Filippine 6
A2 - ???statistics.table.value.countryCode.A2??? 5
ET - Etiopia 5
PE - Perù 5
SA - Arabia Saudita 5
IR - Iran 4
KZ - Kazakistan 4
AL - Albania 3
BA - Bosnia-Erzegovina 3
LT - Lituania 3
MD - Moldavia 3
TN - Tunisia 3
BD - Bangladesh 2
BO - Bolivia 2
CM - Camerun 2
EC - Ecuador 2
EG - Egitto 2
HR - Croazia 2
MY - Malesia 2
NO - Norvegia 2
PT - Portogallo 2
SC - Seychelles 2
SS - ???statistics.table.value.countryCode.SS??? 2
UY - Uruguay 2
AM - Armenia 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BJ - Benin 1
DK - Danimarca 1
HU - Ungheria 1
JO - Giordania 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
MA - Marocco 1
MK - Macedonia 1
MN - Mongolia 1
QA - Qatar 1
UZ - Uzbekistan 1
ZA - Sudafrica 1
Totale 62.981
Salva come PNG Salva come JPEG
Città #
Woodbridge 15.104
Wilmington 14.812
Houston 11.443
Fairfield 1.832
Ann Arbor 1.395
Chandler 1.371
Singapore 1.334
Ashburn 956
Seattle 763
Cambridge 632
Dublin 619
Jacksonville 598
Rome 483
Hong Kong 474
Medford 450
Dearborn 396
New York 330
Beijing 291
Santa Clara 288
Lawrence 215
San Diego 140
Kraków 122
Milan 105
Menlo Park 98
Zhengzhou 87
Moscow 82
Brussels 73
Mülheim 73
Boardman 70
Council Bluffs 60
Helsinki 56
London 54
Jakarta 47
Palo Alto 44
Munich 42
San Mateo 40
Guangzhou 38
Hangzhou 37
Falls Church 35
Norwalk 34
Los Angeles 33
Redwood City 33
Toronto 33
Shanghai 32
Brno 31
Engelhard 31
Sydney 31
Hefei 30
Melbourne 28
Washington 28
Creede 27
Mountain View 25
Nanjing 25
Verona 23
Seoul 22
University Park 22
Nuremberg 21
Canberra 20
Kunming 19
Phoenix 18
São Paulo 15
Jinan 14
La Veta 14
Madrid 14
Naples 14
Tokyo 14
Amsterdam 13
Auburn Hills 13
Olomouc 13
Redmond 12
The Dalles 12
Bari 11
Bologna 11
Dong Ket 11
Florence 11
Frankfurt am Main 11
Genoa 11
Lappeenranta 11
Saint Petersburg 11
Wuhan 11
Cedarhurst 10
Indiana 10
Kilburn 10
Nürnberg 10
Roebling 10
Hounslow 9
Lahore 9
San Jose 9
Turin 9
Auckland 8
Citta 8
Colorado Springs 8
Fuzhou 8
San Francisco 8
Ottawa 7
Padova 7
Shenyang 7
St. George 7
Chengdu 6
Clearwater 6
Totale 56.068
Salva come PNG Salva come JPEG
Nome #
HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels 514
Persistent risk of HBV reactivation despite extensive lamivudine prophylaxis in haematopoietic stem cell transplant recipients who are anti-HBc-positive or HBV-negative recipients with an anti-HBc-positive donor 499
Microbiologic characteristics and predictors of mortality in bloodstream infections in intensive care unit patients: A 1-year, large, prospective surveillance study in 5 Italian hospitals 485
Leflunomide-induced DRESS syndrome 479
Italian consensus Guidelines for the management of hepatitis B virus infections in patients with rheumatoid arthritis 466
A randomized controlled study for the evaluation of the activity of a triple combination of zidovudine, thymosin-alpha(1) and interferon-alpha in HIV-infected individuals with CD4 counts between 200 and 500 cells/mm(3) 464
Human herpesvirus-8 infection in pregnancy and labor: Lack of evidence of vertical transmission 459
Replication capacity, biological phenotype, and drug resistance of HIV strains isolated from patients failing antiretroviral therapy 450
Cellular HIV-1 DNA quantitation in patients during simplification therapy with protease inhibitor-sparing regimens 448
Hepatitis B surface antigen genetic elements critical for immune escape correlate with hepatitis B virus reactivation upon immunosuppression 446
Novelties in evaluation and monitoring of human immunodeficiency virus-1 infection: Is standard virological suppression enough for measuring antiretroviral treatment success? 442
Emergence of KPC-producing Klebsiella pneumoniae in Italy 441
18-Fluoro-2-deoxyglucose positron emission tomography-computed tomography: an additional tool in the diagnosis of prosthetic valve endocarditis. 440
Drug-associated resistance mutations in plasma and peripheral blood mononuclear cells of human immunodeficiency virus type 1-infected patients for whom highly active antiretroviral therapy is failing 439
Prognostic factors of long-term CD4+ count-guided interruption of antiretroviral treatment 438
Clinical predictors and microbiology of ventilator-associated pneumonia in the intensive care unit: a retrospective analysis in six Italian hospitals 437
A stable CC-chemokine receptor (CCR)-5 tropic virus is correlated with the persistence of HIV RNA at less than 2.5 copies in successfully treated naïve subjects. 426
HIV-1 residual viremia and proviral DNA in patients with suppressed plasma viral load (< 400 HIV-RNA cp/ml) during different antiretroviral regimens 425
Characterization of the patterns of drug-resistance mutations in newly diagnosed HIV-1 infected patients naive to the antiretroviral drugs 425
A relapsing inflammatory syndrome and active human herpesvirus 8 infection 423
Association between cellular human immunodeficiency virus DNA level and immunological parameters in patients with undetectable plasma viremia level during highly active antiretroviral therapy 419
Efficient and reproducible new semimicromethod for the detection and titration of HIV in human plasma 419
Infection with human herpesvirus type 8 and Kaposi's sarcoma in a central Italian area formerly endemic for malaria 418
Multiclass HCV resistance to direct-acting antiviral failure in real-life patients advocates for tailored second-line therapies 414
Candida Albicans Peritoneal Infection in a patient with slerosing Encapsulating Peritonitis under continous peritoneal dialysis. Efficacy of intra-abdominal Amphotericin B and negative pressure after failure of a systemic therapy 413
Neutralizing antibodies against autologous human immunodeficiency virus type 1 isolates in patients with increasing CD4 cell counts despite incomplete virus suppression during antiretroviral treatment 411
Drug resistance in B and non-B subtypes amongst subjects recently diagnosed as primary/recent or chronic HIV-infected over the period 2013-2016: impact on susceptibility to first-line strategies including Integrase strand-transfer inhibitors 410
HIV plasma viremia in 22 seropositive subjects [VALUTAZIONE DELLA VIREMIA PLASMATICA DA HIV IN 22 SOGGETTI SIERO-POSITIVI] 409
Reduction of IFN-gamma and IL-2 production by peripheral lymphocytes of HIV-exposed seronegative subjects 409
High seroprevalence of antibodies to human herpesvirus-8 in Egyptian children: evidence of nonsexual transmission. 408
Increase in neutralizing antibody titer against sequential autologous HIV-1 isolates after 16 weeks saquinavir (invirase) treatment 407
High prevalence of M184 mutation among patients with viroimmunologic discordant responses to highly active antiretroviral therapy and outcomes after change of therapy guided by genotypic analysis 406
Interleukin-15 production by monocyte-derived dendritic cells and T cell proliferation in HIV-infected patients with discordant response to highly active antiretroviral therapy 406
A fatal case of invasive fungal sinusitis by Scopulariopsis acremonium in a bone marrow transplant recipient 406
Failure of stavudine-lamivudine combination therapy in antiretroviral-naive patients with AZT-like HIV-1 resistance mutations 405
Cortical sources of resting state electroencephalographic rhythms probe brain function in naïve HIV individuals 405
Human herpesvirus 8 and human herpesvirus 2 infections in prison population 403
Infection with human herpesvirus-8 and its correlation with hepatitis B virus and hepatitis C virus markers among rural populations in Cambodia 402
Raltegravir plasma concentrations in treatment-experienced patients receiving salvage regimens based on raltegravir with and without maraviroc coadministration 402
Prevalence of HHV-8 infection in Albanian adults and association with HBV and HCV 400
Decrease of replicative capacity of HIV isolates after genotypic guided change of therapy 399
Hepatitis B reactivation characterized by HBsAg negativity and anti-HbsAg antibodies persistence in haematopoietic stem cell transplanted patient after lamivudine withdrawal 399
Correlation between changes in plasma HIV RNA levels and in plasma infectivity in response to antiretroviral therapy. 398
Management of carbapenem resistant Klebsiella pneumoniae infections in stem cell transplant recipients: An italian multidisciplinary consensus statement 398
Clinical outcome after 4 years follow-up of HIV-seropositive subjects with incomplete virologic or immunologic response to HAART 397
Prevalence and risk factors for human herpesvirus 8 infection in northern Cameroon 397
Haploidentical, unmanipulated,G-CSF primed bona marrow transplantation for patients with high risk hematological malignancies 395
Plasma Viremia Titration and RNA Quantitation in ICD-p24 Negative HIV Type-1-Infected Patients 394
null 393
HIV phenotype switching during antiretroviral therapy: emergence of saquinavir-resistant strains with less cytopathogenicity 393
Primary human herpesvirus 8 infection in immunocompetent children. 393
A case of rhabdomiolysis associated with raltegravir use 392
Human herpesvirus 8 cytoviraemia rebound in a patient with Kaposi's sarcoma after a short interruption of efficient antiretroviral therapy. 392
Prevalence trend and correlates of HHV-8 infection in HIV-infected patients 390
Advances in herpesvirus diagnosis 387
Viral growth assay to evaluate the replicative capacity of HIV-1 isolates 386
ellular proviral HIV-DNA decline and viral isolation in naïve subjects with <5000 copies/ml of HIV-RNA and >500 x 10(6)/l CD4 cells treated with highly active antiretroviral therapy. 386
KSHV DNA viremia correlates with low CD4+ cell count in Italian males at the time of diagnosis of HIV infection 385
Five human immunodeficiency virus type 1 phenotypic variants with different MT-2 cell tropisms correlate with prognostic markers of disease 383
Ultrasensitive assessment of residual HIV viraemia in HAART-treated patients with persistently undetectable plasma HIV-RNA: A cross-sectional evaluation 382
Infection with human herpesvirus type 8 and human T-cell leukaemia virus type 1 among individuals participating in a case-control study in Havana City, Cuba 381
Procalcitonin is a reliable marker of severe systemic infection in neutropenic haematological patients with mucositis 380
Correlates of HIV, HBV, and HCV infections in a prison inmate population: Results from a multicentre study in Italy 379
Dapsone hypersensitivity syndrome complicated by Scedosporium apiospermum pneumonia in an immunocompetent patient. 379
Gender differences in clinical progression of HIV-1-infected individuals during long-term highly active antiretroviral therapy 373
Reply to 'Different degree of immune recovery using antiretroviral regimens with protease inhibitors or non-nucleosides', by Barreiro et al. [2] 373
HBV, HCV, HDV AND HEV COINFECTIONS IN A COHORT OF HIV POSITIVE PATIENTS IN CAMEROON 373
Secondary integrase resistance mutations found in HIV-1 minority quasispecies in integrase therapy-naive patients have little or no effect on susceptibility to integrase inhibitors 372
Efficacy of cidofovir on human herpesvirus 8 viraemia and Kaposi's sarcoma progression in two patients with AIDS [1] 371
Saquinavir delays the emergence of zidovudine resistance in HIV-1 seropositive patients treated with combination therapy. 371
Non-B HIV type 1 subtypes: Replicative capacity and response to antiretroviral therapy 370
Ultrasensitive assessment of residual HIV viraemia in HAART-treated patients with persistently undetectable plasma HIV-RNA: a cross-sectional evaluation 370
Adherence and genotypic drug resistance mutations in HIV-1-infected patients failing current antiretroviral therapy 369
Usefulness of QuantiFERON®-TB Gold test in psoriatic patients under treatment with tumour necrosis factor blockers 369
HIV-1 integrase genotyping is reliable and reproducible for routine clinical detection of integrase resistance mutations even in patients with low-level viraemia 369
Improvement of ALT decay kinetics by all-oral HCV treatment: Role of NS5A inhibitors and differences with IFN-based regimens 369
Optimal cure rate by personalized HCV regimens in real-life: a proof-of-concept study 369
HHV-8 infection in African children 368
Saquinavir/zidovudine combination in patients with advanced HIV infection and no prior antiretroviral therapy: CD4+ lymphocyte/plasma RNA changes, and emergence of HIV strains with reduced phenotypic sensitivity. 368
Complication of nasal piercing by Staphylococcus aureus endocarditis: a case report and a review of literature. 367
Serological testing for human herpesvirus 8 366
Stavudine protective function and emergence of lamivudine resistance [4] (multiple letters) 366
Development of cellulitis caused by Aeromonas hydrophila in allogeneic hematopoietic transplantation: a case report. 365
Human immunodeficiency virus polymorphisms and zidovudine resistance 365
Infection with human immunodeficiency virus, herpes simplex virus type 2, and human herpes virus 8 in remote villages of southwestern Papua New Guinea 364
High rate of HIV isolation from plasma of asymptomatic patients through polyethylene glycol (PEG) treatment 363
ISS-NIA Study Group. Response to raltegravir-based salvage therapy in HIV-infected patients with hepatitis C virus or hepatitis B virus coinfection. 363
Late hepatitis B virus reactivation after lamivudine prophylaxis interruption in an anti-HBs-positive and anti-HBc-negative patient treated with rituximab-containing therapy 362
Human immunodeficiency virus polymorphisms and zidovudine resistance [3] (multiple letters) 362
Human herpesvirus 8 seropositivity and risk of Kaposi's sarcoma and other acquired immunodeficiency syndrome-related diseases. 359
A very low geno2pheno false positive rate is associated with poor viro-immunological response in drug-naïve patients starting a first-line HAART. 357
HIV-1 dual/mixed tropic isolates show different genetic and phenotypic characteristics and response to maraviroc in vitro 357
Nevirapine use, prolonged antiretroviral therapy and high CD4 nadir values are strongly correlated with undetectable HIV-DNA and -RNA levels and CD4 cell gain. 356
HIV neutralizing antibody titer during structured treatment interruption of highly active antiretroviral therapy 355
Inhibition of dual/mixed tropic HIV-1 isolates by CCR5-inhibitors in primary lymphocytes and macrophages 355
Estimating minimum adult HIV prevalence: A cross-sectional study to assess the characteristics of people living with HIV in Italy 354
Sex issues in HIV-1-infected persons during highly active antiretroviral therapy: A systematic review 353
Human immunodeficiency virus infection of human bone marrow stromal myoid cells 352
Prevalence and risk factors for herpes simplex virus type 2 infection among adolescents and adults in northern Cameroon 349
Structural equation modelling of viral tropism reveals its impact on achieving viral suppression within 6 months in treatment-naive HIV-1-infected patients after combination antiretroviral therapy 345
Totale 39.665
Salva come PNG Salva come JPEG
Categoria #
all - tutte 151.352
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 151.352
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20207.584 0 0 0 0 0 0 1.530 1.343 1.326 1.305 1.012 1.068
2020/20219.138 1.047 991 971 1.214 889 973 1.236 825 210 271 362 149
2021/20222.891 115 228 146 169 124 397 201 146 303 235 173 654
2022/20233.625 325 301 224 519 300 761 271 250 342 31 194 107
2023/20241.740 215 44 167 102 168 353 84 126 39 122 45 275
2024/20254.198 299 1.362 745 648 275 566 303 0 0 0 0 0
Totale 63.955